Director
CurrentThe Krinsky Company (TKC) is a healthcare innovation and growth strategy consulting firm that partners directly with executive leadership and key opinion leaders (payors, providers, self-insured employers, leading clinicians, consultants, and regulatory) across the healthcare ecosystem to help shape the priorities for the strategic planning of high-growth and mission-critical business lines and solutions.To-date, delivered over a dozen successful executive-sponsored innovation & growth engagements for Fortune 500 companies and category-leading start-ups and lead end-to-end client strategy from scope to delivery, manage engagement teams to profitable execution, drive new business development, build and manage KOL network relationships, and ultimately help improve patient experience and outcomes. Selected Engagements:- Created Series B fundraising strategy for top smart baby monitoring company- Led US-market entry analysis for novel UK-based imaging and risk-assessment technology to diagnose active coronary artery disease which measures both inflammation and plaque- Stood up inaugural advisory board and designed key opinion leader engagement plan for leading remote patient monitoring (RPM) company- Launched 6 global advisory communities across radiology, oncology, and cardiology for leading multinational medical device OEM- Led competitive and go-to-market analyses for new at-home diagnostic product launch for top US diagnostics provider- Developed value-selling playbook for leading dialysis player- Executed end-to-end advisory board strategy for IBM Watson for Oncology & Genomics and Watson for Drug Discovery- Appointed interim Program Lead to IBM Watson Health's Oncology & Genomics Data & Evidence Team and helped co-author 3 successful abstract submissions on cognitive technologies for oncology decision-support to the American Society of Clinical Oncology (ASCO)